Work

A multicenter, phase III randomized trial for stage IIIB/IV NSCLC of weekly paclitaxel and carboplatin vs. standard paclitaxel and carboplatin given every three weeks, followed by weekly paclitaxel

Year: 2004

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2004.22.14_suppl.7017

Authors: C. P. Belani, R. V. Larocca, D. A. Rinaldi, W. J. Tester, P. S. Gable, M. C. Perry

Institutions: Naval Medical Center San Diego, Jefferson Einstein Philadelphia Hospital, UPMC Hillman Cancer Center, University of Missouri

Language: English

Topic: Lung Cancer Diagnosis and Treatment

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2599287428

Cites:

Cited by: 16

Related to: 10